These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14618266)

  • 41. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
    Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
    J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
    J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
    Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
    Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
    Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
    Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
    Wang Y; Keskanokwong T; Cheng J
    J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Garlic extracts prevent oxidative stress, hypertrophy and apoptosis in cardiomyocytes: a role for nitric oxide and hydrogen sulfide.
    Louis XL; Murphy R; Thandapilly SJ; Yu L; Netticadan T
    BMC Complement Altern Med; 2012 Aug; 12():140. PubMed ID: 22931510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.
    Xiao D; Dasgupta C; Chen M; Zhang K; Buchholz J; Xu Z; Zhang L
    Cardiovasc Res; 2014 Mar; 101(3):373-82. PubMed ID: 24272874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcolemmal α2-adrenoceptors control protective cardiomyocyte-delimited sympathoadrenal response.
    Kokoz YM; Evdokimovskii EV; Maltsev AV; Nenov MN; Nakipova OV; Averin AS; Pimenov OY; Teplov IY; Berezhnov AV; Reyes S; Alekseev AE
    J Mol Cell Cardiol; 2016 Nov; 100():9-20. PubMed ID: 27659409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of tramadol hydrochloride preconditioning on the activation of nuclear factor-ΚB induced by norepinephrine in cultured neonatal rat cardiomyocytes].
    Lü ZG; Guo Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):646-9. PubMed ID: 24225208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
    Nelson TJ; Balza R; Xiao Q; Misra RP
    J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simplified protocol for culture of murine neonatal cardiomyocytes on nanoscale keratin coated surfaces.
    Jain A; Ravi V; Muhamed J; Chatterjee K; Sundaresan NR
    Int J Cardiol; 2017 Apr; 232():160-170. PubMed ID: 28096043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients.
    Zhang C; Shan XL; Liao YL; Zhao P; Guo W; Wei HC; Lu R
    BMC Complement Altern Med; 2014 Dec; 14():474. PubMed ID: 25488774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
    Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
    Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.